Let's talk medical research

Persistent corneal epithelial defects are more than just an eye injury. The corneal epithelium is an integral part of the eye, tasked with guarding against infection and structural damage. While most injuries to the corneal epithelium are able to heal within a week, these persistent injuries will continue well past the seven-day mark. If they remain unresponsive to standard treatments, the ...

Primary biliary cholangitis (PBC) is a rare, chronic liver disease that impacts 58 out of every 100,000 women and 15 out of every 100,000 men in the United States. It typically progresses slowly, exhibiting no symptoms during the first several years — but in later stages, it can cause debilitating symptoms such as fatigue, itchiness, abdominal pain, swelling of the limbs, jaundice, osteoporosis, ...

At Antidote, our mission is to connect patients with clinical trials is only possible when we understand the individuals that make up the patient population. One way we are able to gain this understanding is by providing our clinical trial search tool, Antidote Match, at no cost to over 300 organizations that we partner with.

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.

At Antidote, our primary mission is to make a connection between patients and clinical trial enrollment opportunities. Our key tool for achieving this goal is Antidote Match, a unique and proprietary clinical trial search platform. By answering a few questions, users are able to quickly see which trials they may be eligible for — and this is made possible through the Antidote annotation process. ...

IgA nephropathy, also known as IgAN or Berger disease, is a common kidney disease that can impact any individual at any age. It is one of the most prevalent kidney diseases other than those caused by diabetes or high blood pressure, but the cause and the cure for this condition remain unknown.

Completing any multi-part task requires organization, coordination, and discipline — and, of course, clinical trials are no exeption. Planning a research study, launching a trial, and keeping things running smoothly requires knowledge and expertise, which is why clinical trial project managers are so vital to the process.

In the medical research industry, successful clinical trial patient recruitment is a known roadblock — in fact, 85% of studies fail to recruit enough patients to complete the research. There are many factors that amplify clinical trial recruitment challenges, but there are also strategic solutions that can be employed for better success.

For medical research to advance, the participation of individuals in a clinical trial is essential. However, accessing trial sites can present an undue burden. A survey about barriers to clinical trial participation found that the primary reason patients declined to enroll in a study was due to the inconvenience associated with travel. This is backed up by research from Deloitte, which reveals ...

Clinical trial recruitment is a significant challenge for sponsors as insufficient patient enrollment can account for delays in up to 80% of all studies. However, even when these studies successfully reach their randomization targets, clinical trial managers must turn their focus on retaining these participants.